• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Insulet

Insulet rises on Street-beating Q4 revenues

February 24, 2021 By Sean Whooley Leave a Comment

Insulet (NSDQ:PODD) shares rose before the market opened today on fourth-quarter results that beat the consensus revenue forecast. The Acton, Mass.-based wearable insulin delivery system developer posted losses of -$17.1 million, or -26¢ per share, on sales of $246.1 million for the three months ended Dec. 31, 2020, for a bottom-line slide into the red on […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

Insulet surpasses Q3 earnings estimates, raises guidance

November 5, 2020 By Brian Buntz

Insulet (NSDQ:PODD) posted third-quarter results after market close yesterday that beat analysts’ consensus for the company. The Acton, Mass.-based tubeless insulin pump manufacturer announced profits of $11.6 million or $0.17 per share on sales of $234 million for the three months ended September 30, 2020, for a bottom-line gain of 13.5% on sales growth of 21% […]

Filed Under: Diabetes, Wall Street Beat Tagged With: COVID-19, diabetes, Insulet, PODD, Shacey Petrovic

How much is COVID-19 affecting procedure volumes for medtech?

October 22, 2020 By Sean Whooley

UBS Financial Services released a report detailing how it expects medtech procedures to potentially keep dipping during the COVID-19 pandemic. The report highlighted a quicker-than-expected recovery in the second quarter after U.S. hospitals began canceling, delaying and deferring elective procedures in late March as the pandemic took hold. However, UBS still expects third-quarter medical procedures […]

Filed Under: Business/Financial News, Featured, Surgical Tagged With: Baxter, becton dickinson, Boston Scientific, coronavirus, COVID-19, Dexcom, Insulet, Masimo, Medtronic, Senseonics, Stryker, UBS, Zimmer Biomet

MedTech 100 roundup: Another high as stocks tick up

August 10, 2020 By Sean Whooley

For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: 3m, Abiomed, Acutus Medical, becton dickinson, Cardinal Health, CHF Solutions Inc., coronavirus, COVID-19, DeviceTalks Weekly, Dow Jones, Gilead Sciences, Insulet, Johnson and Johnson, Livongo, MedTech 100 Index, Orthofix, Pfizer, ResMed Inc., S&P, Siemens Healthineers, Teladoc, TransEnterix, Varian Medical Systems

Insulet up on Street-beating Q2, raised guidance

August 7, 2020 By Sean Whooley

Insulet (NSDQ:PODD) shares ticked up today on second-quarter results that topped the consensus forecast. The Acton, Mass.-based wearable insulin delivery system developer posted profits of $14.4 million, or 22¢ per share, on sales of $226.3 million for the three months ended June 30, 2020, for a bottom-line gain of nearly ten times as much as last […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Insulet

Insulet installs thousands of solar panels at global HQ

June 24, 2020 By Sean Whooley

Insulet (NSDQ:PODD) announced today that its corporate headquarters and manufacturing facility will be powered by solar-based, renewable energy. The Acton, Mass.-based facility is set to turn to the new energy source, beginning this week. The company covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels to, during optimal climate conditions, generate enough energy to […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Insulet

Insulet resumes next-gen Omnipod pivotal study following software issues

June 5, 2020 By Danielle Kirsh

Insulet (NSDQ:PODD) today said it has resumed its pivotal study of its next-generation Omnipod Insulin Management System after pausing the study in March due to a software anomaly. The company paused the study about halfway through completion to correct an issue that could result in the system using an incorrect glucose value that had the potential […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: Insulet

Insulet prices $500m public offering

May 13, 2020 By Sean Whooley

Insulin management technology developer Insulet (NSDQ:PODD) announced that it priced a $500 million common stock offering. The Acton, Mass.-based company set the price of its common stock at $211 per share, with more than 2.3 million shares set to be sold. Insulet also granted underwriters a 30-day option to purchase up to 355,450 additional shares. Morgan […]

Filed Under: Business/Financial News, Diabetes, Funding Roundup Tagged With: Insulet

Insulet posts mixed bag Q1

May 8, 2020 By Sean Whooley

Insulet (NSDQ:PODD) shares dropped slightly today on first-quarter results that topped the consensus revenue forecast but came up short on earnings. The Acton, Mass.-based insulin management technology developer posted losses of -$2.1, or -3¢ per share, on sales of $198 million for the three months ended March 31, 2020, for a bottom-line slide into losses from […]

Filed Under: Business/Financial News, Diabetes, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

DHS warns on Insulet Omnipod

March 23, 2020 By Sean Whooley

The U.S. Dept. of Homeland Security (DHS) issued a medical advisory to warn of vulnerabilities with the Insulet (NSDQ:PODD) Omnipod insulin management system. According to the advisory, the affected insulin pumps are designed to communicate using a wireless RF with Insulet’s personal diabetes manager device, but the RF communication protocol does not properly implement authentication or […]

Filed Under: Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Cybersecurity, Dept. of Homeland Security, Insulet, U.S. Department of Homeland Security

Insulet pauses OmniPod study due to software problem

March 2, 2020 By Danielle Kirsh

Insulet (NSDQ:PODD) today said it is putting a halt on its pivotal study of its Omnipod Horizon Automated Glucose Control System because of a software anomaly. The company is correcting an issue that could result in the system using an incorrect glucose value that has the potential to impact insulin delivery, according to the company. Insulet […]

Filed Under: Diabetes Tagged With: Insulet

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 19
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS